Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagus : Long-term outcome.
[esophageal squamous cell carcinoma]
The
purpose
of
this
work
is
to
report
the
long
-term
outcomes
of
three
-dimensional
conformal
radio
(
chemo
)
therapy
in
the
curative
management
of
esophageal
squamous
cell
carcinoma
(
ESCC
)
.
A
retrospective
analysis
of
patients
treated
with
radio
(
chemo
)
therapy
between
1988
and
2011
at
Klinikum
rechts
der
Isar
,
Technische
Universität
München
was
performed
.
In
all
,
168
patients
received
radio
(
chemo
)
therapy
for
ESCC
in
curative
intention
.
The
median
follow-up
time
was
91
months
(
range
1
-
212
months
)
.
There
were
128
men
and
40
women
with
a
median
age
of
63
years
.
Selection
criteria
for
radio
(
chemo
)
therapy
were
unfit
for
surgery
and
/
or
unresectable
primary
tumor
(
n
 
=
 
146
,
87
 
%
)
or
patients
'
choice
(
n
 
=
 
22
,
13
 
%
)
.
The
majority
of
the
patients
received
a
combination
of
cisplatin
and
5
-
fluorouracil
chemotherapy
with
54
Â
Gy
in
30
Â
fractions
of
radiotherapy
.
The
median
overall
survival
(
OS
)
was
20
months
(
95
 
%
confidence
interval
17
-
23
months
)
.
The
OS
at
2
and
5
years
for
the
whole
cohort
was
41
 
±
 
4
 
%
and
22
 
±
 
3
 
%
,
respectively
.
Forty
patients
(
24
 
%
)
suffered
an
in
-field
recurrence
.
The
most
common
acute
nonhematologic
toxicity
>
grade
Â
2
was
dysphagia
in
35
 
%
of
the
patients
.
Acute
hematologic
toxicity
>
grade
Â
2
was
recorded
in
14
 
%
of
the
patients
.
There
was
no
grade
Â
5
toxicity
observed
during
the
study
.
Poor
ECOG
performance
status
(
0
-
1
vs
.
2
-
3
,
HR
 
=
 
1
.
70
,
p
 
=
 
0
.
002
)
and
weight
loss
≥
 
10
 
%
before
the
start
of
therapy
(
HR
 
=
 
1
.
99
,
p
 
=
 
0
.
001
)
were
among
the
factors
significantly
associated
with
poor
OS
in
multivariate
analysis
.
Three
-dimensional
conformal
definitive
radio
(
chemo
)
therapy
is
well
tolerated
and
leads
to
long
-term
survival
in
more
than
20
 
%
of
patients
with
advanced
disease
and
/
or
contraindication
to
surgery
.
However
,
24
 
%
in
-field
recurrence
remains
a
major
concern
.
Prospective
trials
are
warranted
to
assess
if
a
well-tailored
conformal
radiochemotherapy
can
improve
the
local
control
and
obviate
the
need
for
surgical
resection
in
patients
with
good
general
condition
and
potentially
resectable
tumors
.
Diseases
Validation
Diseases presenting
"good general condition"
symptom
benign recurrent intrahepatic cholestasis
esophageal squamous cell carcinoma
harlequin ichthyosis
lamellar ichthyosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom